Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Colorectal cancer AND FLT3, STK1, 2322, ENSG00000122025, P36888, FLK2, CD135, RP11-153M24_3
72116 results:

  • 1. Ultrasound-guided stellate ganglion block benefits the postoperative recovery of patients undergoing laparoscopic colorectal surgery: a single-center, double-blinded, randomized controlled clinical trial.
    Lu DH; Xu XX; Zhou R; Wang C; Lan LT; Yang XY; Feng X
    BMC Anesthesiol; 2024 Apr; 24(1):137. PubMed ID: 38600490
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Binimetinib in combination with nivolumab or nivolumab and ipilimumab in patients with previously treated microsatellite-stable metastatic colorectal cancer with RAS mutations in an open-label phase 1b/2 study.
    Elez E; Cubillo A; Alfonso PG; Middleton MR; Chau I; Alkuzweny B; Alcasid A; Zhang X; Van Cutsem E
    BMC Cancer; 2024 Apr; 24(1):446. PubMed ID: 38600471
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Impact of hospital volume on failure to rescue for complications requiring reoperation after elective colorectal surgery: multicentre propensity score-matched cohort study.
    Grönroos-Korhonen MT; Koskenvuo LE; Mentula PJ; Nykänen TP; Koskensalo SK; Leppäniemi AK; Sallinen VJ
    BJS Open; 2024 Mar; 8(2):. PubMed ID: 38597158
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Stage at diagnosis of colorectal cancer through diagnostic route: Who should be screened?
    Agatsuma N; Utsumi T; Nishikawa Y; Horimatsu T; Seta T; Yamashita Y; Tanaka Y; Inoue T; Nakanishi Y; Shimizu T; Ohno M; Fukushima A; Nakayama T; Seno H
    World J Gastroenterol; 2024 Mar; 30(10):1368-1376. PubMed ID: 38596494
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Anti-EGFR Rechallenge in Patients With Refractory ctDNA RAS/BRAF wt Metastatic colorectal cancer: A Nonrandomized Controlled Trial.
    Ciardiello D; Martinelli E; Troiani T; Mauri G; Rossini D; Martini G; Napolitano S; Famiglietti V; Del Tufo S; Masi G; Santini D; Avallone A; Pietrantonio F; Lonardi S; Di Maio M; Zampino MG; Fazio N; Bardelli A; Siena S; Cremolini C; Sartore-Bianchi A; Ciardiello F
    JAMA Netw Open; 2024 Apr; 7(4):e245635. PubMed ID: 38592721
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. [Expression of immune checkpoints PD-L1, CTLA4, LAG3 in the microenvironment of colon adenocarcinoma depending on MMR status].
    Naumov SS; Krakhmal NV; Tashireva LA; Vtorushin SV
    Arkh Patol; 2024; 86(2):6-13. PubMed ID: 38591901
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Switching from FOLFIRI plus cetuximab to FOLFIRI plus bevacizumab based on early tumor shrinkage in RAS wild-type metastatic colorectal cancer: A phase II trial (HYBRID).
    Arai H; Tsuda T; Sunakawa Y; Shimokawa M; Akiyoshi K; Tokunaga S; Shoji H; Kunieda K; Kotaka M; Matsumoto T; Nagata Y; Mizukami T; Mizuki F; Danenberg KD; Boku N; Nakajima TE
    Cancer Med; 2024 Apr; 13(7):e7107. PubMed ID: 38591098
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Association of the Advanced Lung cancer Inflammation Index (ALI) and Gustave Roussy Immune (GRIm) score with immune checkpoint inhibitor efficacy in patients with gastrointestinal and lung cancer.
    Jiang H; Li B; Wu M; Wang Q; Li Y
    BMC Cancer; 2024 Apr; 24(1):428. PubMed ID: 38589844
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. The depth of perineural invasion is an independent prognostic factor for stage II colorectal cancer.
    Chen H; Wang C; Chen Z; Huang T; Lin Y; Chen J; Zhang B; He X
    BMC Cancer; 2024 Apr; 24(1):433. PubMed ID: 38589842
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Integration of pathologic characteristics, genetic risk and lifestyle exposure for colorectal cancer survival assessment.
    Xin J; Gu D; Li S; Qian S; Cheng Y; Shao W; Ben S; Chen S; Zhu L; Jin M; Chen K; Hu Z; Zhang Z; Du M; Shen H; Wang M
    Nat Commun; 2024 Apr; 15(1):3042. PubMed ID: 38589358
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Intracorporeal versus extracorporeal anastomosis in laparoscopic right hemicolectomy for overweight colon cancer patients: a case-control study.
    Zhou D; Su J; Yang X; Huang L; Zheng Z; Wei H; Fang J
    Langenbecks Arch Surg; 2024 Apr; 409(1):112. PubMed ID: 38587671
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Analysis of the differential expression of serum miR-21-5p, miR-135-5p, and miR-155-5p by Bifidobacterium triplex viable capsules during the perioperative stage of colorectal cancer.
    Zhang J; Guo J; He R; Li J; Du B; Zhang Y; He R; Cheng H
    Int J Colorectal Dis; 2024 Apr; 39(1):48. PubMed ID: 38584226
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Clinical influence of prophylactic lateral lymph node dissection on oncologic outcomes of patients with mid-low rectal cancer undergoing mesorectal excision: a meta-analysis.
    Ishizuka M; Shibuya N; Hachiya H; Nishi Y; Takayanagi M; Fujita J; Ihara K; Shiraki T; Matsumoto T; Mori S; Iso Y; Nakamura T; Aoki T; Irisawa A
    J Gastrointest Surg; 2024 Apr; 28(4):548-558. PubMed ID: 38583909
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Effect of previous abdominal surgery on robotic-assisted rectal cancer surgery.
    Ferrari D; Violante T; Bhatt H; Gomaa IA; D'Angelo AD; Mathis KL; Larson DW
    J Gastrointest Surg; 2024 Apr; 28(4):513-518. PubMed ID: 38583904
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Clinical study on simultaneous resection of liver metastases combined with hyperthermic intraperitoneal chemotherapy for synchronous colorectal cancer liver metastasis.
    Li W; Ren H; Mou H; Li J; Dong L; Li G; Xing M
    J Gastrointest Surg; 2024 Apr; 28(4):425-433. PubMed ID: 38583892
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. A narrative review on therapeutic potential of naringenin in colorectal cancer: Focusing on molecular and biochemical processes.
    Zamanian MY; Golmohammadi M; Abdullaev B; García MO; Alazbjee AAA; Kumar A; Mohaamed SS; Hussien BM; Khalaj F; Hodaei SM; Shirsalimi N; Moriasi G
    Cell Biochem Funct; 2024 Apr; 42(3):e4011. PubMed ID: 38583080
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Correlation between spleen density and prognostic outcomes in patients with colorectal cancer after curative resection.
    Xiao Y; Wen X; Ying Y; Zhang X; Li L; Wang Z; Su M; Miao S
    BMC Cancer; 2024 Apr; 24(1):425. PubMed ID: 38582845
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Epidemiological and clinicopathological features of KRAS, NRAS, BRAF mutations and MSI in Chinese patients with stage I-III colorectal cancer.
    Wang W; Wang R; Han X; Zhang W; Zhu L; Gu Y
    Medicine (Baltimore); 2024 Apr; 103(14):e37693. PubMed ID: 38579072
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Systematic review and meta-analysis of the management of acute uncomplicated diverticulitis: time to change traditional practice.
    Mohamedahmed AY; Zaman S; Das N; Kakaniaris G; Vakis S; Eccersley J; Thomas P; Husain N
    Int J Colorectal Dis; 2024 Apr; 39(1):47. PubMed ID: 38578433
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Clinical application of the B-type sutured ileostomy in robotic-assisted low anterior resection for rectal cancer: a propensity score matching analysis.
    Sun L; Zhou J; Ji L; Wang W; Zhang Q; Qian C; Zhao S; Li R; Wang D
    J Robot Surg; 2024 Apr; 18(1):159. PubMed ID: 38578352
    [TBL] [Abstract] [Full Text] [Related]  


    of 3606.